AWIIX
Price
$16.05
Change
-$0.01 (-0.06%)
Updated
Jul 18 closing price
Net Assets
667.89M
RLBCX
Price
$36.62
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.16B
Interact to see
Advertisement

AWIIX vs RLBCX

Header iconAWIIX vs RLBCX Comparison
Open Charts AWIIX vs RLBCXBanner chart's image
CIBC Atlas Income Opportunities Instl
Price$16.05
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets667.89M
American Funds American Balanced R3
Price$36.62
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.16B
AWIIX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AWIIX vs. RLBCX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWIIX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. AWIIX (668M). RLBCX pays higher dividends than AWIIX: RLBCX (1.57) vs AWIIX (1.17). AWIIX was incepted earlier than RLBCX: AWIIX (11 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than AWIIX (0.69). RLBCX is a more actively managed with annual turnover of: 44.00 vs. AWIIX (19.00). RLBCX has a lower initial minimum investment than AWIIX: RLBCX (250) vs AWIIX (250000). RLBCX annual gain was more profitable for investors over the last year : 7.12 vs. AWIIX (2.85). AWIIX return over 5 years is better than : 41.91 vs. RLBCX (37.00).
AWIIXRLBCXAWIIX / RLBCX
Total Expense Ratio0.690.8978%
Annual Report Gross Expense Ratio0.690.8978%
Fund Existence11 years23 years-
Gain YTD3.1597.85840%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets668M252B0%
Annual Yield % from dividends1.171.5775%
Returns for 1 year2.857.1240%
Returns for 3 years24.4632.8275%
Returns for 5 years41.9137.00113%
Returns for 10 years104.5759.46176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNO37.690.09
+0.24%
CNO Financial Group
IBIO0.73N/A
+0.14%
iBio
VMEO3.95-0.01
-0.25%
Vimeo
CE57.31-1.19
-2.03%
Celanese Corp
SPRO2.37-0.11
-4.44%
Spero Therapeutics